FDA Adverse Event Injury Summary report: N

EVOLIS TIBIAL BASE PLATE TI PLASMA SPRAYED

MDR report key: 3716502 · Received February 21, 2014

Report

Report Number
3005180920-2014-00014
Event Type
Injury
Date Received
February 21, 2014
Manufacturer
MEDACTA INTERNATIONAL, SA
Product Code
JWH
PMA / PMN Number
K081023
Report Source
Manufacturer report
Reporter Location
ID, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DOCUMENT REVIEW: EVOLI TI PLASMA SPRAYED BASEPLATE - REF. 3031.0003 / LOT 090715 ((B)(4) ITEMS MANUFACTURED). THE ANALYSIS OF THE BATCH RECORD WAS PERFORMED AND ALL THE PARAMETERS WERE FOUND TO BE IN ACCORDANCE WITH THE SPECS IN FORCE AT THE TIME OF THE PRODUCTION. ONE SIMILAR EVENT ON THIS LOT HAS BEEN RECEIVED AND REPORTED TO FDA WITH MDR. EVOLIS TI PLASMA SPRAYED FEMORAL COMPONENT - REF. 3010.006G / LOT. 082374 ((B)(4) ITEMS MANUFACTURED). THE ANALYSIS OF THE BATCH RECORD WAS PERFORMED AND ALL THE PARAMETERS WERE FOUND TO BE IN ACCORDANCE WITH THE SPECS IN FORCE AT THE TIME OF THE PRODUCTION. EVOLIS TI PLASMA SPRAYED SYSTEM IN THE USA IS CLEARED UNDER K081023 (EVOLIS TOTAL KNEE SYSTEM) AS CEMENTED PROSTHESIS, BUT THE SURGEON IMPLANTED IT WITHOUT CEMENT (BOTH FEMUR AND TIBIAL BASEPLATE). IN THE IFU AND SURGICAL TECHNIQUE FOR USA OF EVOLIS, IS CLEARLY INDICATED THAT THE PRODUCT IS TO BE CEMENTED. WITHOUT USING CEMENT, IT IS KNOWN THAT THE RISK OF LOOSENING IS HIGHER THAN CEMENTED SYSTEMS. THE EVENT IS NOT DEVICE RELATED, BUT DUE TO A USE ERROR.

Description of Event or Problem · 1

REVISION SURGERY PERFORMED DUE TO LOOSENING OF THE TIBIAL BASEPLATE AND OF THE FEMORAL COMPONENT. REF # IMP: (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
108833 EVOLIS TIBIAL BASE PLATE TI PLASMA SPRAYED TIBIAL BASE PLATE SIZE 5 JWH MEDACTA INTERNATIONAL, SA 090715

Patients

Seq Age Sex Outcome Treatment
1 LOT #082374| EVOLIS TIBIAL INSERT: CODE 3040.0516, LOT #081360| EVOLIS FEMUR TI PLASMA SPRAYED: CODE 3010.006G,